Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer

Overview of attention for article published in International Journal of Radiation Oncology, Biology, Physics, August 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 11 X posts from 11 X users, with an upper bound of 16,768 followers.

RT @jryckman3: @DrLesterColl @Sunnybrook @ASTRO_org Nice... Real nice! Similar data to UTSW. Looks like SBRT can buy a year (or more) off…

SBRT +TKI

Another study showing the potential benefit of using #SBRT to defer systemic therapy in oligometastatic or oligoprogressive disease. @DrLesterColl @DrRBarroso @rafagadia @Gustavo40678803 @Marta_GustavoN

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.